Although BRCA1 expression showed no significant correlation with the overall survival (OS) or progression‐free survival (PFS) in the overall lung cancer cohort, LUAD patients with elevated BRCA1 expression had a markedly worse OS and PFS compared to those with reduced BRCA1 levels. The gene discussed is BRCA1; the disease is lung carcinoma.